HistoViT: Vision Transformer for Accurate and Scalable Histopathological Cancer Diagnosis

TL;DR

HistoViT introduces a transformer-based deep learning model that significantly improves multi-class histopathological cancer diagnosis accuracy and scalability across various tissue types, outperforming traditional CNNs.

Contribution

This work presents a novel Vision Transformer framework tailored for histopathology, addressing limitations of CNNs and demonstrating superior performance on multiple cancer datasets.

Findings

Achieved over 99% accuracy on breast cancer dataset

Outperformed existing deep learning methods across all tested datasets

Demonstrated robustness and generalizability in digital pathology

Abstract

Accurate and scalable cancer diagnosis remains a critical challenge in modern pathology, particularly for malignancies such as breast, prostate, bone, and cervical, which exhibit complex histological variability. In this study, we propose a transformer-based deep learning framework for multi-class tumor classification in histopathological images. Leveraging a fine-tuned Vision Transformer (ViT) architecture, our method addresses key limitations of conventional convolutional neural networks, offering improved performance, reduced preprocessing requirements, and enhanced scalability across tissue types. To adapt the model for histopathological cancer images, we implement a streamlined preprocessing pipeline that converts tiled whole-slide images into PyTorch tensors and standardizes them through data normalization. This ensures compatibility with the ViT architecture and enhances both convergence stability and overall classification performance. We evaluate our model on four benchmark datasets: ICIAR2018 (breast), SICAPv2 (prostate), UT-Osteosarcoma (bone), and SipakMed (cervical) dataset -- demonstrating consistent outperformance over existing deep learning methods. Our approach achieves classification accuracies of 99.32%, 96.92%, 95.28%, and 96.94% for breast, prostate, bone, and cervical cancers respectively, with area under the ROC curve (AUC) scores exceeding 99% across all datasets. These results confirm the robustness, generalizability, and clinical potential of transformer-based architectures in digital pathology. Our work represents a significant advancement toward reliable, automated, and interpretable cancer diagnosis systems that can alleviate diagnostic burdens and improve healthcare outcomes.